【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Product Profiles
05.1.1 Nexavar
05.1.2 Avastin
05.1.3 Votrient
05.1.4 Afinitor/Votubia
05.1.5 Proleukin
05.1.6 Inlyta
05.1.7 Sutent
05.1.8 Torisel
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.1.1 Types of Kidney Cancer
07.1.2 Benign Kidney Tumors
07.2 Risk Factors
07.2.1 Lifestyle and Job-related Risk Factors
07.2.2 Genetic and Hereditary Risk Factors
07.2.3 Other Risk Factors
07.3 Etiology and Pathogenesis
07.3.1 Inherited Gene Mutations
07.3.2 Acquired Gene Mutations
07.4 Signs and Symptoms
07.5 Diagnosis
07.5.1 Medical History and Physical Exam
07.5.2 Lab Tests
07.5.3 Imaging Tests
07.5.4 Biopsy
07.6 Staging
07.6.1 TNM Staging System
07.7 Management
07.7.1 Surgery
07.7.2 Ablation and Other Local Therapies
07.7.3 Radiation Therapy
07.7.4 Targeted Therapy
07.7.5 Biologic Therapy (Immunotherapy)
07.7.6 Chemotherapy
07.8 Epidemiology
07.9 Economic Burden
08.Pipeline Analysis
08.1 Key Information on Pipeline Candidates
08.1.1 AGS-003
08.1.2 Rencarex
08.1.3 Cometriq
08.1.4 IMA901
08.1.5 AV-951
08.1.6 TroVax
08.1.7 MPDL3280A
08.1.8 Opdivo
08.1.9 Naptumomab Estafenatox
08.1.10 Carfilzomib
09.Market Landscape
09.1 Market Overview
09.2 Market Size and Forecast
09.3 Five Forces Analysis
10.Market Segmentation by Molecule Type
10.1 Small Molecules
10.2 Biologics
11.Geographical Segmentation
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and Their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and Their Impact
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Bayer
19.2.2 F. Hoffmann-La Roche
19.2.3 GlaxoSmithKline
19.2.4 Novartis
19.2.5 Pfizer
19.3 Other and Future Prominent Vendors
20.Global Kidney Cancer Drugs Market: Key Takeaways
21.Key Vendor Analysis
21.1 Bayer
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2014
21.1.4 Business Segmentation by Revenue 2013 and 2014
21.1.5 Geographical Segmentation by Revenue 2014
21.1.6 Business Strategy
21.1.7 Recent Developments
21.1.8 SWOT Analysis
21.2 F. Hoffmann-La Roche
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 GlaxoSmithKline
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2014
21.3.4 Business Segmentation by Revenue 2013 and 2014
21.3.5 Geographical Segmentation by Revenue 2014
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 Novartis
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 Pfizer
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2014
21.5.4 Business Segmentation by Revenue 2013 and 2014
21.5.5 Geographical Segmentation by Revenue 2014
21.5.6 Business Strategy
21.5.7 Key Developments
21.5.8 SWOT Analysis
22.Other Reports in This Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Types of Kidney Cancer
Exhibit 3: Types of Benign Kidney Tumor
Exhibit 4: Prevalence of Kidney Cancer by Gender
Exhibit 5: Global Kidney Cancer Drugs Market: Pipeline Portfolio
Exhibit 6: Global Kidney Cancer Drugs Market 2014-2019 ($ billions)
Exhibit 7: Segmentation of Global Kidney Cancer Drugs Market by Molecule Type
Exhibit 8: Segmentation of Global Kidney Cancer Drugs Market by Geography 2014
Exhibit 9: Major Drivers in Global Kidney Cancer Drugs Market
Exhibit 10: Major Challenges in Global Kidney Cancer Drugs Market
Exhibit 11: Major Trends of Global Kidney Cancer Drugs Market
Exhibit 12: Bayer: YoY Growth and Revenue of Nexavar 2010-2014 ($ millions)
Exhibit 13: F. Hoffmann-La Roche: YoY Growth and Revenue of Avastin 2010-2014 ($ millions)
Exhibit 14: GlaxoSmithKline: YoY Growth and Revenue of Votrient 2010-2014 ($ millions)
Exhibit 15: GlaxoSmithKline: Revenue of Votrient by Region 2010-2014 ($ millions)
Exhibit 16: Novartis: YoY Growth and Revenue of Afinitor 2010-2014 ($ millions)
Exhibit 17: Novartis: Revenue of Afinitor by Region 2012-2013 ($ millions)
Exhibit 18: Novartis: YoY Growth and Revenue of Proleukin 2012-2014 ($ millions)
Exhibit 19: Pfizer: YoY Growth and Revenue of Inlyta 2012-2014 ($ millions)
Exhibit 20: Pfizer: YoY Growth and Revenue of Sutent 2010-2014 ($ millions)
Exhibit 21: Global Kidney Cancer Drugs Market: Key Takeaways
Exhibit 22: Bayer: Business Segmentation by Revenue 2014
Exhibit 23: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 24: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 25: Business Segmentation of F. Hoffmann-La Roche 2013
Exhibit 26: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 27: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 28: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 29: GlaxoSmithKline: Business Segmentation by Revenue 2014
Exhibit 30: GlaxoSmithKline: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 31: GlaxoSmithKline: Geographical Segmentation by Revenue 2014
Exhibit 32: Novartis: Business Segmentation
Exhibit 33: Novartis: Revenue by Business Segmentation 2013
Exhibit 34: Novartis: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 35: Novartis: Revenue by Geographical Segmentation 2013
Exhibit 36: Pfizer: Business Segmentation by Revenue 2014
Exhibit 37: Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 38: Pfizer: Geographical Segmentation by Revenue 2014
【レポート販売概要】
■ タイトル:腎臓がん治療薬の世界市場2015-2019■ 英文:Global Kidney Cancer Drugs Market 2015-2019
■ 発行日:2015年7月1日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6298
■ 調査対象地域:グローバル
- 世界のインフルエンザ検査市場The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Com …
- HORIBA, Ltd.:市場シェア分析HORIBA, Ltd. Market Share Analysis Summary GlobalData’s new report, “HORIBA, Ltd. Market Share Analysis” provides in-depth information on Horiba, Ltd.’s market position in the different medical equipment markets it operates in. The report provides Horiba, Ltd. market share information in one key market category – Haematology. The report also provides data and information on the overall competitive …
- ヨーロッパのIVD(体外診断)市場2016-2020About IVD Market in Europe IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufact …
- スマートアドバイザーの世界市場予測(~2021年)The smart advisors market size is estimated to grow from USD 703.3 Million in 2016 and to USD 3,172.0 Million by 2021, at a CAGR of 35.2% from 2016 to 2021. Some of the major factors that are driving the growth of the market include the proliferating demand of intelligent customer engagement, increasing penetration of websites & mobile applications, and surge in demand of automated patient managem …
- スケジューリング及びオートメーションソフトウェアの世界市場:ワークロード管理ソフトウェア、データセンター自動化ソフトウェアAbout Scheduling and Automation Software Scheduling and Automation Software automates, manages, and controls the workflow throughout the IT infrastructure in an organization. The software align IT with business objectives for better performance and reduce in total cost of ownership. It consists of two sub-markets. The datacenter automation software controls and monitors the process of the datacent …
- 5Gインフラの世界市場予測(~2026年):通信インフラ、ネットワーク技術、チップセット、用途、地域別分析The 5G infrastructure market is estimated to be valued at USD 2.86 Billion in 2020 and it is further expected to reach USD 33.72 Billion by 2026, at a CAGR of 50.9% between 2020 and 2026. The forecast period for this report is considered between 2020 and 2026. The major factors driving the growth of the 5G infrastructure market include increasing demand for mobile data services, rising importance …
- 生体フォトニクス技術の世界市場:バイオイメージング、バイオアッセイ、光学バイオセンサ、バイオチップ、医療機器The global biophotonics market is expected to reach USD 50.18 Billion by 2020 from USD 26.26 Billion in 2014, at a CAGR of 11.5% from 2015 to 2020. This market is primarily driven by the emergence of nanotechnology, significant technological advancements, increasing demand for home-based POC devices, aging population, and growing lifestyle diseases. Biophotonics technologies enable better imaging …
- 遺伝子治療の世界市場:研究開発および売上予測2016-2026Gene Therapies – Discover Revenue Predictions and See How Treating Cancer, Cardiovascular Disorders and Other Chronic Diseases Progresses What does the future hold for gene therapy? What progress and sales are possible? Avoid struggles to gain that business data. Instead find the best places for expanding revenues, also understanding trends, technologies, therapies and opportunities. Visiongain’s …
- 世界の3Dプリンター市場機会分析3D printing technology is considered to be one of the fastest growing technologies with numerous uses and applications for 3D printers and services across different application sectors. It has revolutionized various industries such as medical, aerospace, consumer products and automotive. This technology facilitates the printing of products of finest quality with highest accuracy by building the pr …
- 自動車スロットルバイワイヤ(TBW)システムの世界市場2016-2020About Throttle by Wire A by-wire technology is an innovation which replaces conventional physical connections (like cables and mechanical linkages) with a wire that transmits electronic signals. In TBWs, a throttle position sensor placed adjacent to the gas pedal recognizes how far the pedal has been pressed. In most modern TBW systems, the sensor used is a Hall Effect throttle position sensor (H- …
- 機能性粉末の世界市場:原材料別(大豆、小麦、米、トウモロコシ、豆類、その他)、種類別(特殊粉、調理済み粉末)、製品物(添加物含有粉末、遺伝子組み換え粉末)、用途別(ベーカリー製品、スープ ・ソース、ヌードル・パスタ、レディトゥイート製品)、地域別予測Global Functional Flours Probe Market to reach USD 91.22 billion by 2025. Global Functional Flours Probe Market valued approximately USD 48.22 billion in 2016 is forecasted to grow with a healthy growth rate of more than 7.34% over the forecast period 2018-2025. The major factors speculated to augment the markets are increasing trade of the functional flour and escalating consumer spending along w …
- Venous Leg Ulcers (Crural ulcer):グローバル臨床試験レビューH1, 2013Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013" provides data on the Venous Leg Ulcers (Crural ulcer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Leg Ulcers (Crural ulcer). It inclu …
- レーザクラッディング装置の世界市場2017-2021About Global Laser Cladding Equipment Market Cladding is a process of bonding two dissimilar methods together. This process is different from other methods like fusion welding, which is used to fasten two different metals together. The cladding is used in a variety of industries to improve the surface and near surface properties of metal, which had become worn through use. Cladding primarily invol …
- 無人地上車両(UGV)の世界市場予測(~2021年)“Demand for increased efficiency in commercial and defense operations is the key factor influencing the growth of the unmanned ground vehicle market”The unmanned ground vehicle market is estimated to be valued at USD 1.49 billion in 2016 and is projected to reach USD 2.63 billion by 2021, at a CAGR of 12.14% during the forecast period. The increasing demand for enhanced efficiency, human safety, a …
- ポリウレタンフォームの世界市場予測(~2023年)“The polyurethane foam market is projected to grow at a CAGR of 8.0% from 2018 to 2023.” The polyurethane foam market is projected to grow from USD 54.19 billion in 2018 to USD 79.77 billion by 2023, at a CAGR of 8.0% from 2018 to 2023. Increase in the consumption of polyurethane foam in emerging Asian countries is expected to drive the growth of the polyurethane foam market. Due to the growing co …